Cambridge Enterprise Ventures Fund I

Cambridge Enterprise Ventures

Status

ACTIVE

Global HQ

Cambridge, United Kingdom

Countries of investment

United Kingdom

Investment stages

Pre-Seed
Seed
Series A

Industries

Deep Tech
Biotech
Healthcare

About
Cambridge Enterprise Ventures is the dedicated venture capital arm of the University of Cambridge. It invests in and supports high-potential deep-tech and life science companies originating from the university's research. The firm's mission is to provide patient, long-term capital and strategic support to help its portfolio companies succeed globally.

Min check size: $50K
Max check size: $1.5M
Fund size: Unlock
NPS: Unlock

Investment Thesis

Cambridge Enterprise Ventures is the early-stage venture capital investor for the University of Cambridge, focusing on deep-tech and life science spin-outs and start-ups. The firm invests from pre-seed to Series A and beyond, providing patient capital to its portfolio companies. Its unique position within the Cambridge ecosystem allows it to leverage the University's network, resources, and intellectual property to support the growth of world-changing companies.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

The leadership team consists of individuals with PhDs from Cambridge and over 10-20 years of experience each in venture capital, technology commercialization, and life sciences. Key managers like Dr. Anne Dobrée and Dr. Christine Martin bring CEO experience and long tenures at other prominent UK innovation investors like Touchstone Innovations. The team's expertise is deeply rooted in the Cambridge ecosystem, with a strong focus on life sciences and deep technology, leveraging backgrounds from firms like Parkwalk Advisors and IP Group plc.